213 related articles for article (PubMed ID: 36292115)
21. Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus.
Liu J; Wang C; Wang YT; Liu JX; Zhou TH; Yao SK; Chen G
Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E62-E71. PubMed ID: 37285598
[TBL] [Abstract][Full Text] [Related]
22. The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus.
Bhardwaj M; Mazumder PM
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; ():. PubMed ID: 38861011
[TBL] [Abstract][Full Text] [Related]
23. Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study.
Xing Y; Chen J; Liu J; Ma H
Diabetes Metab Syndr Obes; 2022; 15():383-394. PubMed ID: 35177915
[TBL] [Abstract][Full Text] [Related]
24. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
Xue Y; Xu J; Li M; Gao Y
Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
[TBL] [Abstract][Full Text] [Related]
25. The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study.
Tutunchi H; Naeini F; Ebrahimi-Mameghani M; Mobasseri M; Naghshi S; Ostadrahimi A
Int J Clin Pract; 2021 Jun; 75(6):e14131. PubMed ID: 33683797
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
27. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
[TBL] [Abstract][Full Text] [Related]
28. Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.
Guan C; Fu S; Zhen D; Yang K; An J; Wang Y; Ma C; Jiang N; Zhao N; Liu J; Yang F; Tang X
J Diabetes Res; 2022; 2022():8429847. PubMed ID: 35127953
[TBL] [Abstract][Full Text] [Related]
29. Association of Uric Acid to Creatinine Ratio with Metabolic Dysfunction-Associated Fatty Liver in Non-Obese Individuals Without Type 2 Diabetes Mellitus.
Liu J; Wang C; Wang Y; Yao S
Diabetes Metab Syndr Obes; 2024; 17():131-142. PubMed ID: 38222031
[TBL] [Abstract][Full Text] [Related]
30. The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China.
Yang RX; Zou ZS; Zhong BH; Deng H; He FP; Shi JP; Zhao CY; Mi YQ; Zhou YJ; Di FS; Zheng RD; Du Q; Shang J; Popovic B; Chen J; Fan JG
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):426-432. PubMed ID: 34246549
[TBL] [Abstract][Full Text] [Related]
31. Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults.
Duan S; Yang D; Xia H; Ren Z; Chen J; Yao S
Front Endocrinol (Lausanne); 2022; 13():1004855. PubMed ID: 36187093
[TBL] [Abstract][Full Text] [Related]
32. Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients.
Song P; Xu L; Xu J; Zhang HQ; Yu CX; Guan QB; Zhao M; Zhang X
Curr Vasc Pharmacol; 2018; 16(6):589-595. PubMed ID: 29299987
[TBL] [Abstract][Full Text] [Related]
33. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
[TBL] [Abstract][Full Text] [Related]
34. Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study.
Liu J; Duan S; Wang C; Wang Y; Peng H; Niu Z; Yao S
Front Endocrinol (Lausanne); 2022; 13():1035418. PubMed ID: 36531447
[TBL] [Abstract][Full Text] [Related]
35. Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease.
Turecký L; Kupčová V; Urfinová M; Repiský M; Uhlíková E
Vnitr Lek; 2021; 67(E-2):4-8. PubMed ID: 34074098
[TBL] [Abstract][Full Text] [Related]
36. Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database.
Li XM; Liu SL; He YJ; Shu JC
BMC Gastroenterol; 2024 Mar; 24(1):109. PubMed ID: 38491451
[TBL] [Abstract][Full Text] [Related]
37. Clinical Utility of the Logarithmically Transformed Ratio of Triglycerides-to- High-Density Lipoprotein Cholesterol and Its Relationship with Other Atherosclerosis-Related Lipid Factors in Type 2 Diabetes.
Viktorinova A; Fabryova L; Malickova D; Choudhury S; Krizko M
Metab Syndr Relat Disord; 2021 May; 19(4):205-212. PubMed ID: 33373539
[No Abstract] [Full Text] [Related]
38. [Associations between serum GDF15 and glycolipid metabolism disorder in metabolic associated fatty liver patients].
Li X; Yu XM; Li EH; Chen PH; Zheng LM; Zhang S
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):987-992. PubMed ID: 37528037
[No Abstract] [Full Text] [Related]
39. Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease.
Duan SJ; Ren ZY; Zheng T; Peng HY; Niu ZH; Xia H; Chen JL; Zhou YC; Wang RR; Yao SK
World J Gastroenterol; 2022 Sep; 28(36):5364-5379. PubMed ID: 36185625
[TBL] [Abstract][Full Text] [Related]
40. A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients.
Ma YH; Zhao L; Xian XD; Yang D; Huang W; Wang YH; Mueller O; Chang E; Konigshofer Y; Van-Cleve M; Liu G; Yang JK
Clin Chem Lab Med; 2009; 47(9):1067-72. PubMed ID: 19728847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
